# Cholecalciferol in Treating Patients With Myelodysplastic Syndrome

> **NCT00068276** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Leukemia
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms

## Interventions

- **DIETARY_SUPPLEMENT:** cholecalciferol

## Key facts

- **NCT ID:** NCT00068276
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2005-06
- **Final completion:** 2006-09
- **Target enrollment:** — (—)
- **Last updated:** 2018-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00068276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00068276, "Cholecalciferol in Treating Patients With Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00068276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*